SGLT2 Inhibitors and the CFP Method: Who Benefits and Who Should Be Cautious

SGLT2 Inhibitors and the CFP Method: Who Benefits and Who Should Be Cautious Welcome to CFP Weight Loss. I'm Russell Clark, Nurse Practitioner. Today, we're exploring SGLT2 Inhibitors and the CFP Method: Who Benefits and Who Should Be Cautious. ... I'm going to keep this calm and practical, and stick to what the clinical evidence actually says. ... We'll touch on SGLT2 Inhibitors, CFP Method, Tirzepatide Reset — especially as they apply to real people over forty. ... SGLT2 inhibitors have emerged as powerful tools in metabolic health, working alongside structured protocols like the Clark Fasting Protocol (CFP) to drive meaningful fat loss and insulin sensitivity gains. When integrated into the 30-Week Tirzepatide Reset . framework, these medications complement GLP-1/GIP agonists by targeting different pathways—primarily promoting urinary glucose excretion while the CFP method emphasizes strategic cycling, ancestral complex carbohydrates , and metabolic flow. Understanding who thrives with this combination and who needs extra caution is essential for safe, sustainable results. ... Listen at CFP Weight Loss — clinical guide with Russell Clark, FNP-C. Read more: https://blog.cfpweightloss.com/sglt2-inhibitors-and-the-cfp-method-who-it-helps-and-who-should-be-careful-konh6d